Skip to main content



Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Icons
Spotlight Poster Icon
Spotlight Poster Icon
Spotlight Winner
Spotlight Winner

  • Friday, Aug 26th
    5:30 PM – 5:45 PM CEST
    The Impact of Using Pictorial Aids in Caregivers' Understanding of Patient Information Leaflets of Pediatric Pain Medications: A Quasi-experimental Study
    Location: C1M1
    Presenting Author: Aljoharah M. Algabbani – Saudi Food and Drug Authority (Saudi FDA)
    Co-Author: Khalid Alzahrani – KSU
    Co-Author: Sarah Sayed – KSU
    Co-Author: Deema Sorani – KSUMC
    Co-Author: Omar Almohammed – KSU
    Co-Author: Amani Alqahtani – SAudi FDA
    Benefit-Risk Assessment, Communication, and Evaluation (BRACE)
  • Friday, Aug 26th
    6:15 PM – 6:30 PM CEST
    Anticoagulant Therapy and Risk of Kidney Disease - A Nationwide Cohort Study
    Location: C1M1
    Presenting Author: Ane Emilie Friis Vestergaard – Department of Clinical Epidemiology, Aarhus University
    Co-Author: Christian Christiansen, MD,PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
    Co-Author: Simon Kok Jensen – Department of Clinical Epidemiology, Aarhus University
    Co-Author: Kasper Adelborg – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University & Aarhus University Hospital, Aarhus, Denmark
    Co-Author: Henrik Birn – Department of Clinical Medicine, Aarhus University, Denmark
    Benefit-Risk Assessment, Communication, and Evaluation (BRACE)
  • Saturday, Aug 27th
    2:00 PM – 2:05 PM CEST
    Mortality Among Parkinson's Disease Patients Treated with Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare
    Location: C1M2
    Presenting Author: Sandia Akhtar – Acumen, LLC
    Co-Author: Andrew Mosholder, MPH, MD – US Food and Drug Administration
    Co-Author: Yong Ma – Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
    Co-Author: Gerald Podskalny – US Food and Drug Administration
    Co-Author: Yuhui Feng – Acumen LLc
    Co-Author: Hai Lyu – Acumen LLC
    Co-Author: Jiemin Liao – Acumen LLC
    Co-Author: Yuqin Wei – Acumen LLC
    Co-Author: Michael Wernecke – Acumen LLC
    Co-Author: Kira Leishear – US Food and Drug Administration
    Co-Author: Lorene Nelson – Stanford University
    Co-Author: Thomas E MaCurdy – Acumen LLC
    Co-Author: Jeffrey Kelman – CMS
    Co-Author: David Graham, MPH, MD – US Food and Drug Administration
    Benefit-Risk Assessment, Communication, and Evaluation (BRACE)
  • Saturday, Aug 27th
    2:05 PM – 2:10 PM CEST
    Post-market Safety Communication for New Drugs Approved in Australia 2010-2016
    Location: C1M2
    Presenting Author: Barbara Mintzes, PhD – University of Sydney
    Co-Author: Alice Bhasale, PhD – Australian Commission on Safety and Quality in HealthCare
    Co-Author: Lucy Perry – University of Sydney
    Co-Author: Eliza McEwin – University of Sydney
    Co-Author: Annim Mohammad – University of Sydney
    Co-Author: Ashleigh Hooimeyer – University of Sydney
    Co-Author: Atse Huisman – Utrecht University
    Benefit-Risk Assessment, Communication, and Evaluation (BRACE)
  • Saturday, Aug 27th
    2:10 PM – 2:15 PM CEST
    Hydroxyzine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada: a longitudinal cohort study
    Location: C1M2
    Presenting Author: Richard L. Morrow, PhD – Therapeutics Initiative, Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia
    Co-Author: Barbara Mintzes, PhD – University of Sydney
    Co-Author: Patrick Souverein – Utrecht University
    Co-Author: Christine E. Hallgreen – Copenhagen Centre for Regulatory Science, University of Copenhagen
    Co-Author: Bilal Ahmed – University of British Columbia
    Co-Author: Elizabeth Roughead – University of South Australia
    Co-Author: Marie Louise De Bruin – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG Utrecht, The Netherlands
    Co-Author: Sarah Kristiansen – Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark
    Co-Author: Joel Lexchin – York University
    Co-Author: Anna Kemp-Casey – University of South Australia
    Co-Author: Ingrid Sketris, FISPE – Dalhousie University
    Co-Author: Dee Mangin, MBChB (Otago), DPH (Otago), FRNZCGP (NZ) – McMaster University
    Co-Author: Sallie-Anne Pearson, PhD – Centre for Big Data Research in Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia
    Co-Author: Lorri Puil – University of British Columbia
    Co-Author: Ruth Lopert – George Washington University
    Co-Author: Lisa Bero – University of Colorado Anschutz Medical Campus
    Co-Author: Danijela Gnjidic – University of Sydney
    Co-Author: Ameet Sarpatwari, PhD, JD – Brigham and Women’s Hospital and Harvard Medical School
    Co-Author: Colin Dormuth – University of British Columbia
    Benefit-Risk Assessment, Communication, and Evaluation (BRACE)
  • Saturday, Aug 27th
    2:15 PM – 2:20 PM CEST
    Duration of the evaluation of additional risk minimization measures: the need for speed
    Location: C1M2
    Presenting Author: Sharon Essink, MSc – Utrecht University
    Co-Author: Inge Zomerdijk – Medicines Evaluation Board, Utrecht, The Netherlands.
    Co-Author: Sabine Straus, MD, PhD – Medicines Evaluation Board, Utrecht, The Netherlands.
    Co-Author: Marie Louise De Bruin – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG Utrecht, The Netherlands
    Benefit-Risk Assessment, Communication, and Evaluation (BRACE)
  • Saturday, Aug 27th
    4:15 PM – 5:45 PM CEST
    Drug Safety on the Cutting Edge: What are the Implications of EMA's To-Be-Released Risk Minimisation Guidance on Pharmacoepidemiological Methods and Practice in Developed and Developing Countries?
    Location: C1M0
    Presenting Author: Meredith Y. Smith, FISPE, PhD, MPA – Evidera | PPD
    Author: Priya Bahri – European Medicines Agency
    Author: Elaine Morrato, DrPH, MPH – Loyola University Chicago
    Author: Parthasarathi Gurumurthy, PharmD, PhD – Botswana Medicines Regulatory Authority
    Benefit-Risk Assessment, Communication, and Evaluation (BRACE)
  • Sunday, Aug 28th
    10:30 AM – 12:00 PM CEST
    Updating the Public on COVID-19 Vaccine Safety - Considerations for Pharmacoepidemiologists
    Location: Congress Hall D5
    Presenting Author: Mathias Moellebaek – Copenhagen Centre for Regulatory Science, University of Copenhagen
    Author: Priya Bahri – European Medicines Agency
    Author: Nabarun Dasgupta – UNC Gillings School of Global Public Health
    Author: Barbara Mintzes, PhD – University of Sydney
    Author: Anton Pottegård, PhD, MSc – University of Southern Denmark
    Author: Peter Mol, PharmD, PhD – University Medical Center Groningen
    Benefit-Risk Assessment, Communication, and Evaluation (BRACE)